支气管肺发育不良定义变迁及相关研究进展

朱雪萍

中国儿童保健杂志 ›› 2019, Vol. 27 ›› Issue (10) : 1047-1049.

PDF(427 KB)
PDF(427 KB)
中国儿童保健杂志 ›› 2019, Vol. 27 ›› Issue (10) : 1047-1049. DOI: 10.11852/zgetbjzz2019-0831
专家笔谈

支气管肺发育不良定义变迁及相关研究进展

  • 朱雪萍
作者信息 +

Changes in the definition of bronchopulmonary dysplasia and related researches progress

  • ZHU Xue-ping
Author information +
文章历史 +

摘要

支气管肺发育不良(BPD)是新生儿的一种慢性肺部疾病,严重影响患儿存活率及生活质量。其病因及发病机制复杂,治疗上无特效药,临床重点在于预防。其中,BPD的定义经过一系列演变,仍存在争议,因此对BPD的定义变迁进行归纳总结十分必要。

Abstract

Bronchopulmonary dysplasia(BPD) is a kind of chronic lung disease in neonates which can severely impact patients′ survival rate and life quality.Given its complicated etiology and pathogenesis, there is still no specific treatment for BPD.Therefore, the key intervention of BPD should focus on the prevention rather than treatment.However, the definition of BPD has been developing for decades with controversy.Thus, it is very critical to summarize the developement of BPD definition.

关键词

早产儿 / 支气管肺发育不良 / 定义 / 诊断 / 病因 / 发病机制

Key words

preterm infants / bronchopulmonary dysplasia / definition / diagnosis / etiology / pathogenesis

引用本文

导出引用
朱雪萍. 支气管肺发育不良定义变迁及相关研究进展[J]. 中国儿童保健杂志. 2019, 27(10): 1047-1049 https://doi.org/10.11852/zgetbjzz2019-0831
ZHU Xue-ping. Changes in the definition of bronchopulmonary dysplasia and related researches progress[J]. Chinese Journal of Child Health Care. 2019, 27(10): 1047-1049 https://doi.org/10.11852/zgetbjzz2019-0831
中图分类号: R722.6   

参考文献

[1] Simones AA, Beisang DJ, Panoskaltsis-Mortari A, et al.Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review[J].Pediatr Res,2018,83(1-2): 308-317.
[2] Mwaniki MK, Atieno M, Lawn JE, et al.Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review[J].Lancet,2012,379(9814):445-452.
[3] McEvoy CT, Jain L, Schmidt B, et al.Bronchopulmonary D ysplasia: NHLBI workshop on the primary prevention of chronic lung diseases [J].Ann Am Thorac Soci,2014,11(Suppl 3):1446-1453.
[4] Fischer HS, Buhrer C.Avoiding endotracheal ventilation to prevent bronchopulmonarydysplasia:a meta-analysis[J].Pediatrics,2013,132(5):e1351-e1360.
[5] Sahni M,Mowes AK.Bronchopulmonary dysplasia[J/OL].StatPearls,2019.https://www.ncbi.nlm.nih.gov/books/NBK539879/?report=printable.
[6] Stoll BJ, Hansen NI, Bell EF, et al.Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network[J].Pediatrics,2010,126(3):443-456.
[7] Stoll BJ, Hansen NI, Bell EF, et al.Trends in care practices, morbidity, and mortality of extremely preterm neonates,1993-2012[J].JAMA,2015,314:1039-1051.
[8] Islam JY, Keller RL, Aschner JL, et al.Understanding the short-and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia[J].Am J Respir Crit Care Med,2015,192(2):134-156.
[9] Northway W.Pulmonary disease following respiratory therapy of hyaline membrane disease:bronchopulmoary dysplasia[J].N Eng J M,1967,276:357-368.
[10] Gregory GA, Kitterman JA, Phibbs RH, et al.Treatment of the idiopathic respiratory-distress Syndrome with continuous positive airway pressure-NEJM[J].New England Journal of Medicine,1971,284(24):1333-1340.
[11] Avery ME, Mead J.Surface properties in relation to atelectasis and hyaline membrane disease[J].AMA J Dis Child,1959,97(5, Part 1):517-523.
[12] Tooley WH.Epidemiology of bronchopulmonary dysplasia[J].Pediatr,1979,95:851-858.
[13] Bancalari E, Abdenour GE, Feller R, et al.Bronchopulmon ary dysplasia: clinical presentation[J].Pediatr,1979,95(5):819-823.
[14] Shennan AT, Dunn MS, Ohlsson A, et al.Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period[J].Pediatrics,1988,82(4):527-532.
[15] Jobe AH, Bancalari E.Bronchopulmonary dysplasia[J].Am J Respir Crit Care Medi,2001,163(7):1723-1729.
[16] Walsh MC, Yao Q, Gettner P, et al.Impact of a physiologi c definition on bronchopulmonary dysplasia rates[J].Pediatrics,2004,114(5):1305-1311.
[17] Shahzad T, Radajewski S, Chao CM, et al.Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development[J].Mol Cell Pediatr,2016,3(1):23.
[18] 早产儿支气管肺发育不良发生率及高危因素的多中心回顾调查分析[J].中华儿科杂志,2011,49(9):655-662.
[19] KalikkotThekkeveedu R, Guaman MC, Shivanna B.Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology[J].Respiratory Medicine,2017,132:170-177.
[20] Serafina P, Luisa TM, Giuseppe B.Oxidative stress and br onchopulmonary dysplasia[J].Clin Neonatol,2012,1(3):109-114.
[21] Wang J, Dong W.Oxidative stress and bronchopulmonary dysplasia[J].Gene,2018,678:117-183.
[22] Won CC, Juyoung L, Youn OJ, et al.Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats[J].Pediatr Res,2016,79(2):287-294.
[23] Lowe J, Watkins WJ, Edwards MO, et al.Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preter infants updated systematic review and meta-analysis[J].Pediatr Infect Dise J,2014,33(7):697.
[24] Tracy MK, Berkelhamer SK.Bronchopulmonary Dysplasia and Pulmonary Outcomes of Prematurity[J].Pediatr Ann,2019,48(4):e148-e153.
[25] Ratel RM,Kandefer S,Walsh MC,et al.Causes and timing of death in extremely premature infants from 2000 through 2011[J].N Engl J Med,2015,372(4):331-340.
[26] Hjalmarson O, Sandberg K.Abnormal lung function in healthy preterm infants[J].Am J of Respir Crit Care Med,2002,165(1):83-87.
[37] Martinez FD .Early-life origins of chronic obstructive pulmonary disease[J].N Engl J Med,2016,375(9):871-878.
[28] Austin ED,Kawut SM, Gladwin MT, et al.Pulmonary hypertension: NHLBI workshop on the primary prevention of chronic lung diseases[J].Ann Am Thorac Soc,2014,11(Suppl 3):178.

基金

国家自然科学基金面上项目(81771626);江苏省妇幼健康重点人才项目(FRC201731);苏州市民生科技-关键技术应用研究项目(SS201644);苏州市卫生计生委临床重点病种诊疗技术专项(LCZX201612)

PDF(427 KB)

Accesses

Citation

Detail

段落导航
相关文章

/